State Board of Administration of Florida Retirement System’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $537K | Hold |
56,361
| – | – | ﹤0.01% | 1494 |
|
|
2025
Q4 | $440K | Hold |
56,361
| – | – | ﹤0.01% | 1595 |
|
|
2025
Q3 | $428K | Hold |
56,361
| – | – | ﹤0.01% | 1611 |
|
|
2025
Q2 | $505K | Hold |
56,361
| – | – | ﹤0.01% | 1522 |
|
|
2025
Q1 | $423K | Hold |
56,361
| – | – | ﹤0.01% | 1560 |
|
|
2024
Q4 | $424K | Hold |
56,361
| – | – | ﹤0.01% | 1603 |
|
|
2024
Q3 | $428K | Hold |
56,361
| – | – | ﹤0.01% | 1635 |
|
|
2024
Q2 | $348K | Buy |
56,361
+90
| +0.2% | +$497 | ﹤0.01% | 1710 |
|
|
2024
Q1 | $469K | Sell |
56,271
-90
| -0.2% | -$506 | ﹤0.01% | 1568 |
|
|
2023
Q4 | $338K | Hold |
56,361
| – | – | ﹤0.01% | 1819 |
|
|
2023
Q3 | $399K | Buy |
56,361
+90
| +0.2% | +$647 | ﹤0.01% | 1672 |
|
|
2023
Q2 | $396K | Hold |
56,271
| – | – | ﹤0.01% | 1707 |
|
|
2023
Q1 | $469K | Hold |
56,271
| – | – | ﹤0.01% | 1623 |
|
|
2022
Q4 | $646K | Sell |
56,271
-4,910
| -8% | -$61.2K | ﹤0.01% | 1454 |
|
|
2022
Q3 | $771K | Hold |
61,181
| – | – | ﹤0.01% | 1337 |
|
|
2022
Q2 | $647K | Hold |
61,181
| – | – | ﹤0.01% | 1503 |
|
|
2022
Q1 | $995K | Sell |
61,181
-13,040
| -18% | -$209K | ﹤0.01% | 1366 |
|
|
2021
Q4 | $1.03M | Sell |
74,221
-1
| -0% | -$13 | ﹤0.01% | 1423 |
|
|
2021
Q3 | $1.07M | Hold |
74,222
| – | – | ﹤0.01% | 1391 |
|
|
2021
Q2 | $1.17M | Buy |
74,222
+6,474
| +10% | +$88K | ﹤0.01% | 1359 |
|
|
2021
Q1 | $689K | Hold |
67,748
| – | – | ﹤0.01% | 1628 |
|
|
2020
Q4 | $505K | Buy |
67,748
+2,030
| +3% | +$10.5K | ﹤0.01% | 1766 |
|
|
2020
Q3 | $226K | Hold |
65,718
| – | – | ﹤0.01% | 2013 |
|
|
2020
Q2 | $313K | Buy |
65,718
+11,654
| +22% | +$46.5K | ﹤0.01% | 1865 |
|
|
2020
Q1 | $108K | Sell |
54,064
-370
| -0.7% | -$1.02K | ﹤0.01% | 2054 |
|
|
2019
Q4 | $188K | Hold |
54,434
| – | – | ﹤0.01% | 2131 |
|
|
2019
Q3 | $156K | Hold |
54,434
| – | – | ﹤0.01% | 2146 |
|
|
2019
Q2 | $206K | Hold |
54,434
| – | – | ﹤0.01% | 2125 |
|
|
2019
Q1 | $443K | Hold |
54,434
| – | – | ﹤0.01% | 1822 |
|
|
2018
Q4 | $439K | Hold |
54,434
| – | – | ﹤0.01% | 1782 |
|
|
2018
Q3 | $415K | Hold |
54,434
| – | – | ﹤0.01% | 1970 |
|
|
2018
Q2 | $312K | Hold |
54,434
| – | – | ﹤0.01% | 2087 |
|
|
2018
Q1 | $260K | Hold |
54,434
| – | – | ﹤0.01% | 2132 |
|
|
2017
Q4 | $267K | Hold |
54,434
| – | – | ﹤0.01% | 2146 |
|
|
2017
Q3 | $285K | Hold |
54,434
| – | – | ﹤0.01% | 2138 |
|
|
2017
Q2 | $303K | Hold |
54,434
| – | – | ﹤0.01% | 2119 |
|
|
2017
Q1 | $457K | Hold |
54,434
| – | – | ﹤0.01% | 1877 |
|
|
2016
Q4 | $345K | Hold |
54,434
| – | – | ﹤0.01% | 2024 |
|
|
2016
Q3 | $240K | Hold |
54,434
| – | – | ﹤0.01% | 2173 |
|
|
2016
Q2 | $155K | Hold |
54,434
| – | – | ﹤0.01% | 2266 |
|
|
2016
Q1 | $154K | Hold |
54,434
| – | – | ﹤0.01% | 2265 |
|
|
2015
Q4 | $562K | Hold |
54,434
| – | – | ﹤0.01% | 1798 |
|
|
2015
Q3 | $621K | Hold |
54,434
| – | – | ﹤0.01% | 1730 |
|
|
2015
Q2 | $813K | Buy |
54,434
+953
| +2% | +$10.8K | ﹤0.01% | 1676 |
|
|
2015
Q1 | $483K | Buy |
53,481
+355
| +0.7% | +$3.68K | ﹤0.01% | 1964 |
|
|
2014
Q4 | $646K | Hold |
53,126
| – | – | ﹤0.01% | 1832 |
|
|
2014
Q3 | $520K | Hold |
53,126
| – | – | ﹤0.01% | 1941 |
|
|
2014
Q2 | $677K | Buy |
+53,126
| New | +$517K | ﹤0.01% | 1863 |
|
|
2013
Q3 | – | Sell |
-40,133
| Closed | -$62K | – | 2530 |
|
|
2013
Q2 | $62K | Buy |
+40,133
| New | +$69.2K | ﹤0.01% | 2546 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC
State Board of Administration of Florida Retirement System's BCRX Position: Q1 2026 in Review
State Board of Administration of Florida Retirement System held its BioCryst Pharmaceuticals (BCRX) position steady in Q1 2026 at 56,361 shares worth $537K. The position accounts for ﹤0.01% of the portfolio, ranked #1494.
State Board of Administration of Florida Retirement System first reported a position in BCRX in Q2 2013 and has held it in 49 quarters since. The position peaked at $1.17M in Q2 2021. 301 funds tracked by Wall St. Rank hold BCRX as of Q1 2026.
- State Board of Administration of Florida Retirement System held 56,361 shares of BioCryst Pharmaceuticals worth $537K as of Q1 2026.
- State Board of Administration of Florida Retirement System left its BioCryst Pharmaceuticals share count unchanged in Q1 2026.
- BioCryst Pharmaceuticals made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q1 2026, its #1494 holding.
- State Board of Administration of Florida Retirement System first reported a position in BioCryst Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
- State Board of Administration of Florida Retirement System's BioCryst Pharmaceuticals position peaked at $1.17M in Q2 2021.
- 301 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q1 2026.
Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2026, filed 8 May 2026.